A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsOptimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferasemiRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells.Extracellular RNAs: development as biomarkers of human disease.Critical role of HMGA proteins in cancer cell chemoresistance.IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry.Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in GlioblastomaPrimate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease.MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.Circulating biomarkers for gliomas.MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 statusHMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.ExRNA in Biofluids as Biomarkers for Brain Tumors.DNA methylation in adult diffuse gliomas.Biomarkers and therapeutic advances in glioblastoma multiforme.The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.MicroRNA in Glioblastoma: An Overview.Evaluation of apoptosis induced by exposure to antineoplastic drugs in peripheral blood lymphocytes of nurses.Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.Repair gene O6 -methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation.MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
P2860
Q26747273-B9FB439D-C710-4101-865E-A83367C9CC2EQ26796590-473058A0-9CEC-4CEE-B5D2-4D881A87BD4BQ27333913-0CA5622E-51FF-430E-B172-03B29D0E8192Q34478948-8672EA2C-A404-43D2-8111-F44A7B5EA8E4Q35132876-96F023D8-E348-49A8-9745-5D5F91D50DA0Q35694536-DD4D6E9D-5E4D-4416-BC7A-03659D4376E0Q35997569-499D6C35-733F-492B-AC4F-A549D4FB438DQ36006446-BE6A6691-C23C-4DD8-BFF8-2BF432E92B0AQ36308084-3A6F1B7E-575B-4624-BD59-BCC35482B8B6Q36562205-D3BCB744-7B4B-4817-8FC6-A1DA0193FBF0Q36648767-0DE5956B-B83F-42ED-B674-E910938C831BQ36681437-FFD45AF3-0034-4CBA-828B-521C3A53C08FQ36729351-09E97873-63B6-43F4-B754-648BE4434671Q37706967-3E87C659-3195-4E48-A286-A3826971AD8FQ38586617-21F3E908-B01D-4CF8-836A-47E7084CAB1EQ38692922-0BBE4ACA-5D3E-4AFF-98C1-B68F386D4203Q38751430-EA6C5D4D-606E-494B-9F0A-8F2D6E6996AAQ38754084-6AAC46A4-AF93-4EB2-BC64-E7419E7ED59EQ38779883-14BB9B22-1EF7-48EA-8E2F-31B411242806Q38781031-C20EB722-AD15-48CA-AFB9-EC06409A7528Q38861997-34861EC6-026D-4A48-AB53-987ED4BA1A09Q40070524-C413304B-DC07-49DC-84FE-EE60B0A7C5E7Q42696213-C0357AC1-C5D2-4DEC-9E10-AC1F12EDFDF9Q47142132-CA79AABF-8A82-445C-BFAB-5BA3BA24AE71Q47749421-3B5D5363-547D-4423-B3BA-71C29FD85012Q48137109-A3028848-1AE6-40C9-91E4-C0B936A87D17Q48256976-C6B7E74F-EBD7-4DEF-8E68-DB9477765B93Q52562698-9427915E-CA17-4656-A4E2-249901A8D49BQ52629217-AF6FB92F-6D2B-4614-A0BF-804BE098B408
P2860
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@ast
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@en
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@nl
type
label
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@ast
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@en
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@nl
prefLabel
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@ast
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@en
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@nl
P2093
P2860
P356
P1433
P1476
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.
@en
P2093
Bob S Carter
Clark C Chen
Deepa Kushwaha
Diahnn Futalan
Dipanjan Chowdhury
Jann Sarkaria
Johnny C Akers
Kimberly Ng
Thien Nguyen
P2860
P304
P356
10.18632/ONCOTARGET.1974
P407
P577
2014-06-01T00:00:00Z